Schedule 13G ownership disclosure
BELLEVUE LIFE SCNCS AQSTN CO
Common Stock, par value $0.0001 per share · CUSIP: 079174108
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bellevue Global Life Science Investors, LLC
Shares: 1,355,000.00 · Class: 58.4%
- BCM Europe AG
Shares: 680,000.00 · Class: 29.3%
- Bellevue Capital Management LLC
Shares: 2,035,000.00 · Class: 87.7%
- Kuk Hyoun Hwang
Shares: 2,035,000.00 · Class: 87.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-012372
- Form type
- SCHEDULE 13G/A
- Filer
- Bellevue Global Life Science Investors LLC
- CIK
- CIK 1953768
- Filed
- Feb 11, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership